Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-005264
Filing Date
2024-11-14
Accepted
2024-11-14 16:36:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 armistice-inm093024a2.htm SC 13G/A 89155
  Complete submission text file 0001172661-24-005264.txt   90708
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Subject) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-91842 | Film No.: 241463419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)